Interferon-α

1
Reactions 1321 - 2 Oct 2010 Interferon-α Fatigue, anorexia, anxiety and depression: case report A 57-year-old man, who had a history of diabetes mellitus, developed fatigue, anorexia, anxiety and depression following treatment with interferon-α for metastatic renal cell carcinoma. The man began treatment in April 2007 with IM natural human interferon-α [Sumiferon] 3 × 10 6 IU three times weekly for bulky lung metastases. The day after each injection, he developed a fever. After seven injections, his dose was increased to 6 × 10 6 IU and maintained for five injections. Soon after, he presented with general fatigue, anorexia, a high level of anxiety and depression. Interferon-α was discontinued. Two weeks later, the man’s mental status normalised and he was maintained on 6 × 10 6 IU once a week. Interferon-α was withheld in April 2009 after 88 administrations due to worsening of his diabetes. He remained in complete remission 14 months after stopping interferon-α. Orikasa S, et al. Complete remission of bulky lung metastases of renal cell carcinoma by low-dose interferon-alpha monotherapy. International Journal of Urology 17: 818-819, No. 9, Sep 2010. Available from: URL: http:// dx.doi.org/10.1111/j.1442-2042.2010.02598.x - Japan 803040336 1 Reactions 2 Oct 2010 No. 1321 0114-9954/10/1321-0001/$14.95 © 2010 Adis Data Information BV. All rights reserved

Transcript of Interferon-α

Page 1: Interferon-α

Reactions 1321 - 2 Oct 2010

Interferon-αFatigue, anorexia, anxiety and depression: casereport

A 57-year-old man, who had a history of diabetesmellitus, developed fatigue, anorexia, anxiety anddepression following treatment with interferon-α formetastatic renal cell carcinoma.

The man began treatment in April 2007 with IM naturalhuman interferon-α [Sumiferon] 3 × 106IU three timesweekly for bulky lung metastases. The day after eachinjection, he developed a fever. After seven injections, hisdose was increased to 6 × 106IU and maintained for fiveinjections. Soon after, he presented with general fatigue,anorexia, a high level of anxiety and depression.

Interferon-α was discontinued. Two weeks later, theman’s mental status normalised and he was maintained on6 × 106IU once a week. Interferon-α was withheld in April2009 after 88 administrations due to worsening of hisdiabetes. He remained in complete remission 14 monthsafter stopping interferon-α.Orikasa S, et al. Complete remission of bulky lung metastases of renal cellcarcinoma by low-dose interferon-alpha monotherapy. International Journal ofUrology 17: 818-819, No. 9, Sep 2010. Available from: URL: http://dx.doi.org/10.1111/j.1442-2042.2010.02598.x - Japan 803040336

1

Reactions 2 Oct 2010 No. 13210114-9954/10/1321-0001/$14.95 © 2010 Adis Data Information BV. All rights reserved